Dupilumab Treatment for Prurigo Nodularis and Pruritis
Prurigo Nodularis
Authors Ross Tanis MD MS, Katalin Ferenczi MD, and B Michael Payette MD MBAB present a case where they demonstrated that treatment of Prurigo Nodularis (PN) with dupilumab significantly decreased pruritis and the size and number of new lesions after 2 months of treatment. INTRODUCTION Prurigo nodularis is an intensely pruritic disease in which dome-shaped papulonodules result from chronic scr …
What’s New for Itch
Brian Berman, MD
by Bobbak (Bobby) Mansouri, MD, FAAD on
Dermatologists are well aware of the difficulty in managing itchy patients. Itch can be caused by a number of cutaneous and extracutaneous diseases. Regardless of the etiology, itch is one of the most frustrating symptoms of patients and management dilemmas for dermatologists. At the 16th Annual ODAC conference, Dr. Brian Berman reviewed some of the emerging therapies for the treatment of itch a …
Coastal Dermatology Symposium – Clinical Pearls Round Up – Part II
Coastal Dermatology Symposium
by Angelo Landriscina, MD on
The second of a two-part series with clinical pearls from the 2018 Coastal Dermatology Symposium.  Be sure not to miss all the useful points in Part I. From Dr. Julie Harper’s talk “The Latest on Acne” OCPs are still a viable treatment for female patients with acne.  You should be sure to take a thorough history to elucidate any risk factors for venous thromboembolism such as smoking …